Uniphar plc UPR.IR Stock
Uniphar plc Price Chart
Uniphar plc UPR.IR Financial and Trading Overview
| Uniphar plc stock price | 2.7 EUR |
| Previous Close | 3.25 EUR |
| Open | 3.26 EUR |
| Bid | 3.24 EUR x N/A |
| Ask | 3.25 EUR x N/A |
| Day's Range | 3.23 - 3.26 EUR |
| 52 Week Range | 2.8 - 3.84 EUR |
| Volume | 13.46K EUR |
| Avg. Volume | 355.95K EUR |
| Market Cap | 892.68M EUR |
| Beta (5Y Monthly) | 0.713894 |
| PE Ratio (TTM) | 19.058823 |
| EPS (TTM) | 0.16 EUR |
| Forward Dividend & Yield | 0.02 (0.52%) |
| Ex-Dividend Date | April 20, 2023 |
| 1y Target Est | 4.4 EUR |
UPR.IR Valuation Measures
| Enterprise Value | 1.07B EUR |
| Trailing P/E | 19.058823 |
| Forward P/E | 15.428572 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.43110937 |
| Price/Book (mrq) | 3.0537229 |
| Enterprise Value/Revenue | 0.515 |
| Enterprise Value/EBITDA | 12.071 |
Trading Information
Uniphar plc Stock Price History
| Beta (5Y Monthly) | 0.713894 |
| 52-Week Change | 10.01% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.84 EUR |
| 52 Week Low | 2.8 EUR |
| 50-Day Moving Average | 3.1 EUR |
| 200-Day Moving Average | 3.21 EUR |
UPR.IR Share Statistics
| Avg. Volume (3 month) | 355.95K EUR |
| Avg. Daily Volume (10-Days) | 348.99K EUR |
| Shares Outstanding | 273.02M |
| Float | 226.09M |
| Short Ratio | N/A |
| % Held by Insiders | 4.90% |
| % Held by Institutions | 41.60% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.017 |
| Trailing Annual Dividend Yield | 0.52% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.1024 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2021 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 2.20% |
| Operating Margin (ttm) | 3.68% |
| Gross Margin | 14.81% |
| EBITDA Margin | 4.26% |
Management Effectiveness
| Return on Assets (ttm) | 4.63% |
| Return on Equity (ttm) | 16.88% |
Income Statement
| Revenue (ttm) | 2.07B EUR |
| Revenue Per Share (ttm) | 7.6 EUR |
| Quarterly Revenue Growth (yoy) | 2.70% |
| Gross Profit (ttm) | 306.74M EUR |
| EBITDA | 88.4M EUR |
| Net Income Avi to Common (ttm) | 45.59M EUR |
| Diluted EPS (ttm) | 0.17 |
| Quarterly Earnings Growth (yoy) | 116.29% |
Balance Sheet
| Total Cash (mrq) | 78.03M EUR |
| Total Cash Per Share (mrq) | 0.29 EUR |
| Total Debt (mrq) | 245.4M EUR |
| Total Debt/Equity (mrq) | 97.55 EUR |
| Current Ratio (mrq) | 0.985 |
| Book Value Per Share (mrq) | 1.061 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 82.83M EUR |
| Levered Free Cash Flow (ttm) | 47.4M EUR |
Profile of Uniphar plc
| Country | Ireland |
| State | N/A |
| City | Dublin |
| Address | 4045 Kingswood Road |
| ZIP | D24 V06K |
| Phone | 353 1 428 7777 |
| Website | https://www.uniphar.ie |
| Industry | Medical Distribution |
| Sector(s) | Healthcare |
| Full Time Employees | 2850 |
Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, and internationally. The company operates through three divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. The Commercial & Clinical division offers outsourced sales, marketing, and multichannel account management services to pharmaco-medical manufacturers; and distribution and support services to medical device manufacturers. The Product Access division provides on demand services, which offers access to pharmaco-medical products and treatments by developing valuable relationships and interactions between manufacturers and other healthcare stakeholders; and exclusive access services that provides bespoke distribution partnerships to pharmaceutical partners for key brands. The Supply Chain & Retail division engages in pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons; and operates a network of pharmacies under the Life, Allcare, and Hickey's brands. It also offers pharmacy support, pharmaceutical supply chain, specialist nursing and infusion, medical device distribution, healthcare technology, data intelligence and consultancy services, pharmaceutical advisory, medical affairs, and online pharmacy and product fostering services, as well as data solutions for pharma industry. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.
Q&A For Uniphar plc Stock
What is a current UPR.IR stock price?
Uniphar plc UPR.IR stock price today per share is 2.7 EUR.
How to purchase Uniphar plc stock?
You can buy UPR.IR shares on the Irish exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Uniphar plc?
The stock symbol or ticker of Uniphar plc is UPR.IR.
Which industry does the Uniphar plc company belong to?
The Uniphar plc industry is Medical Distribution.
How many shares does Uniphar plc have in circulation?
The max supply of Uniphar plc shares is 273.02M.
What is Uniphar plc Price to Earnings Ratio (PE Ratio)?
Uniphar plc PE Ratio is 16.87500000 now.
What was Uniphar plc earnings per share over the trailing 12 months (TTM)?
Uniphar plc EPS is 0.16 EUR over the trailing 12 months.
Which sector does the Uniphar plc company belong to?
The Uniphar plc sector is Healthcare.